William Blair on Cullinan Oncology Inc. (CGEM): 'We continue to see multiple opportunities for upside to Cullinan shares'
Tweet Send to a Friend
William Blair analyst Matt Phipps reiterated an Outperform rating on Cullinan Oncology Inc. (NASDAQ: CGEM).The analyst comments "On Wednesday, June ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
